Clinical trial
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly…
NCT00392327 · Children's Oncology Group, Other · Active, not recruiting
Key facts
| NCT number | NCT00392327 |
|---|---|
| Title | Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET |
| Official title | Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anaplastic Medulloblastoma, Medulloblastoma |
| Intervention type | Biological, Drug, Other, Procedure, Radiation |
| Interventions | Biospecimen Collection, Carboplatin, Cisplatin, Cyclophosphamide, Filgrastim, Isotretinoin, Lumbar Puncture, Magnetic Resonance Imaging, Quality-of-Life Assessment, Radiation Therapy and 1 more |
| Enrollment | 379 |
| Start date | May 23, 2007 |
| Primary completion | Jun 30, 2019 |
| Completion | Jun 30, 2028 |
| First posted | Oct 26, 2006 |
| Last update posted | Jun 13, 2025 |
| Countries | Australia, Canada, Netherlands, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: